Average Co-Inventor Count = 6.77
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (22 from 3,923 patents)
2. Xenon Pharmaceuticals Inc. (5 from 109 patents)
3. Millennium Pharmaceuticals Limited (4 from 850 patents)
4. Shionogi Bioresearch Corporation (1 from 5 patents)
5. Shiongi Bioresearch Corp. (1 from 1 patent)
6. Novartis Pharma Gmbh (8 patents)
28 patents:
1. 12252482 - Pyrazolopyridine derivatives and uses thereof
2. 12172984 - Pyrazolopyridine derivatives and uses thereof
3. 11787785 - Pyrazolopyridine derivatives and uses thereof
4. 11672799 - 1,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditions
5. 11566022 - 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
6. 11229648 - 1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions
7. 10758533 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
8. 10654828 - Indole derivatives and uses thereof
9. 10633350 - Diphenyl derivatives and uses thereof
10. 10195196 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
11. 9545404 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
12. 9187426 - Organic compounds
13. 9040712 - Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
14. 8729263 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
15. 8501746 - Organic compounds